Sample Policy
Free Sample / Freight Charged / to final agreement
Expert Support
Pharmaceutical Team
Liraglutide is a GLP-1 receptor agonist that has completed NDC registration. It is a human glucagon-like peptide-1 (GLP-1) analog that lowers blood glucose by increasing insulin secretion, inhibiting glucagon secretion, and delaying gastric emptying. In addition, it can also inhibit the appetite center, reduce food intake, and help with weight management.
204656-20-2
≥99%
C172H265N43O51
3751.2
| Parameter | Specification |
|---|---|
| CAS Number | 204656-20-2 |
| Purity | ≥99% |
| Molar mass | 3751.2 |
| Molecular formula | C172H265N43O51 |
| Sequence | H-His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(Pal-γ-Glu)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH |
| Sample Policy | Free Sample / Freight Charged / to final agreement |
Contact our pharmaceutical team for custom peptide synthesis, bulk orders, and technical support for your drug development needs.
